Medical Care Technologies Inc. Introduces AI-Powered Facial Analysis for Diabetic Retinopathy Detection
Medical Care Technologies (OTC:MDCE) has launched an innovative AI Facial Health Risk Estimator designed to detect diabetic retinopathy in its early stages. The technology analyzes facial images to identify retinal abnormalities such as microaneurysms, hemorrhages, and vascular leakage, offering a non-invasive screening solution.
CEO Marshall Perkins emphasized that this AI-powered system aims to address the challenge of late diagnosis in diabetic retinopathy, which is a leading cause of preventable blindness globally. The technology promises to improve accessibility to early screening and enhance patient outcomes through early detection.
Medical Care Technologies (OTC:MDCE) ha lanciato un innovativo Stima del rischio per la salute facciale tramite IA progettata per rilevare la retinopatia diabetica nelle sue fasi iniziali. La tecnologia analizza le immagini del volto per identificare anomalie della retina come microaneurismi, emorragie e fuga vascolare, offrendo una soluzione di screening non invasiva.
Il CEO Marshall Perkins ha sottolineato che questo sistema basato sull’IA mira ad affrontare la sfida della diagnosi tardiva della retinopatia diabetica, una delle principali cause di cecità prevenibile a livello globale. La tecnologia promette di migliorare l’accessibilità allo screening precoce e di migliorare gli esiti per i pazienti attraverso il rilevamento tempestivo.
Medical Care Technologies (OTC:MDCE) ha lanzado un innovador Estimador de Riesgo de Salud Facial impulsado por IA diseñado para detectar la retinopatía diabética en sus etapas tempranas. La tecnología analiza imágenes faciales para identificar anomalías de la retina como microaneurismas, hemorragias y fugas vasculares, ofreciendo una solución de cribado no invasiva.
El CEO Marshall Perkins destacó que este sistema impulsado por IA tiene como objetivo abordar el desafío del diagnóstico tardío en la retinopatía diabética, una de las principales causas de ceguera prevenible a nivel mundial. La tecnología promete mejorar la accesibilidad al cribado temprano y mejorar los resultados de los pacientes mediante la detección temprana.
Medical Care Technologies(OTC:MDCE)은 초기 단계에서 당뇨병성 망막병증을 발견하기 위해 고안된 혁신적인 AI 얼굴 건강 위험 추정기를 출시했습니다. 이 기술은 얼굴 이미지를 분석하여 망막의 이상(미세동맥류, 출혈, 혈관 누출 등)을 식별하고 비침습적 선별 솔루션을 제공합니다.
CEO Marshall Perkins는 이 AI 기반 시스템이 전 세계적으로 지연된 진단 문제를 해결하는 것을 목표로 한다고 강조했습니다. 이는 당뇨병성 망막병증의 주요 원인 중 하나인 예방 가능한 실명의 감소에 기여할 것이라고 합니다. 기술은 조기 선별에 대한 접근성을 높이고 조기 발견을 통해 환자 결과를 개선할 것을 약속합니다.
Medical Care Technologies (OTC:MDCE) a lancé un Estimateur de Risque de Santé Faciale par IA innovant conçu pour détecter la rétinopathie diabétique à ses premiers stades. La technologie analyse des images du visage pour identifier des anomalies rétiniennes telles que les microanévrismes, les hémorragies et les fuites vasculaires, offrant une solution de dépistage non invasive.
Le PDG Marshall Perkins a souligné que ce système alimenté par l’IA vise à relever le défi du diagnostic tardif de la rétinopathie diabétique, l’une des principales causes de cécité évitable dans le monde. La technologie promet d’améliorer l’accès au dépistage précoce et d’améliorer les résultats des patients grâce à une détection précoce.
Medical Care Technologies (OTC:MDCE) hat einen innovativen KI-Gesundheitsrisiko-Schätzer für das Gesicht eingeführt, der darauf ausgelegt ist, diabetische Retinopathie in ihren frühen Stadien zu erkennen. Die Technologie analysiert Gesichtsaufnahmen, um Netzhautanomalien wie Mikroaneurismen, Blutungen und Gefäßleckagen zu identifizieren, und bietet eine nicht invasive Screening-Lösung.
CEO Marshall Perkins betonte, dass dieses KI-gestützte System darauf abzielt, das Problem verspäteter Diagnosen bei der diabetischen Retinopathie anzugehen, eine der Hauptursachen vermeidbarer Blindheit weltweit. Die Technologie verspricht, den Zugang zu frühem Screening zu verbessern und die Patientenergebnisse durch frühzeitige Erkennung zu verbessern.
Medical Care Technologies (OTC:MDCE) أطلقت أداة مبتكرة جديدة باسم مقدر مخاطر صحة الوجه بالذكاء الاصطناعي مصممة للكشف عن اعتلال الشبكية السكري في مراحله المبكرة. تقوم التقنية بتحليل صور الوجه لتحديد تشوهات الشبكية مثل الخراجات الدقيقة والدموع والارتشاح الوعائي، مما يوفر حلاً فحصياً غير جراحي.
وحسب ما ذكره الرئيس التنفيذي مارشال بيركنز، فإن هذا النظام المدعوم بالذكاء الاصطناعي يهدف إلى معالجة مشكلة التشخيص المتأخر للاعتلال الشبكي السكري، وهي أحد الأسباب الرئيسية للعمى القابل للوقاية في العالم. وتعد التقنية بتحسين إمكانية الوصول إلى فحص مبكر وتحسين نتائج المرضى من خلال الكشف المبكر.
Medical Care Technologies (OTC:MDCE) 已推出一款创新的基于人工智能的
首席执行官马歇尔·帕金斯强调，这一 AI 驱动系统旨在解决糖尿病性视网膜病变诊断延迟的问题——这是全球可预防性失明的主要原因之一。该技术有望提高早期筛查的可及性，并通过早期发现改善患者结局。
- Introduction of innovative AI technology for early diabetic retinopathy detection
- Non-invasive screening method increases accessibility
- Addresses a significant global health issue (preventable blindness)
- No clinical validation data provided
- No regulatory approval status mentioned
MESA, ARIZONA / ACCESS Newswire / September 26, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) unveiled its AI Facial Health Risk Estimator for early detection of diabetic retinopathy, a leading cause of preventable blindness worldwide.
The system analyzes subtle retinal cues captured from standard facial imaging, identifying microaneurysms, hemorrhages, and vascular leakage, allowing for non-invasive, accessible early screening.
"Diabetic retinopathy often goes undiagnosed until vision loss occurs," said Marshall Perkins, CEO of MDCE. "Our AI technology allows earlier detection, broader screening access, and better patient outcomes."
Company Websites: www.medicalcaretechnologies.com | www.mdcestock.com
About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTC PINK: MDCE) is at the forefront of AI-driven preventive healthcare, providing early detection tools across systemic, ocular, and dermatological conditions.
Safe Harbor Statement:
Forward-looking statements are included in this release. Risks and uncertainties may cause actual results to differ materially.
Contact:
Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com
SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)
View the original press release on ACCESS Newswire
FAQ
What is Medical Care Technologies' (MDCE) new AI technology for diabetic retinopathy?
How does MDCE's AI Facial Health Risk Estimator work?
What problem does MDCE's new AI technology solve?
Who is the CEO of Medical Care Technologies (MDCE)?
What are the potential benefits of MDCE's AI screening technology?
